300111.SHE Zhejiang Sunflower Light Energy
- Market cap
- CNY 4.18B
- P/E
- -
- P/B
- 6.03x
- ROE
- -3.1%
- Dividend yield
- 0.00%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300111.SHE undervalued?
Graham numberThe Graham number of Zhejiang Sunflower Light Energy cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Zhejiang Sunflower Light Energy fundamental analysis
No fundamental analysis for Zhejiang Sunflower Light Energy yet.
Zhejiang Sunflower Light Energy stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Zhejiang Sunflower Light Energy
Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sales of anti-infective, cardiovascular, and digestive system drugs in China and internationally. It offers clarithromycin raw materials, an anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, mycoplasma pneumonia, and urethritis and cervicitis; clarithromycin tablets; azithromycin dispersib…
Full company profileZhejiang Sunflower Light Energy financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Zhejiang Sunflower Light Energy annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.60B | 1.53B | 900M | 837M | 287M | 297M | 336M | 338M | 330M | 272M | 229M |
| Gross Profit | 335M | 179M | 7.94M | 142M | 102M | 109M | 96.2M | 83.6M | 74.2M | 56.8M | 47.6M |
| Operating Income | 83.0M | 3.70M | -720M | -72.4M | 73.8M | 54.5M | 5.91M | 26.0M | 12.4M | -5.99M | -6.03M |
| EBITDA | 266M | 214M | -904M | 4.28M | 92.8M | 88.7M | 21.2M | 47.3M | 31.3M | 10.0M | -17.6M |
| Net Income | 30.6M | 23.7M | -1.12B | -115M | 55.9M | 53.4M | -1.14M | 21.7M | 7.83M | -4.38M | -20.8M |
| EPS | 0.03 | 0.02 | -1.00 | -0.10 | 0.05 | 0.05 | 0.00 | 0.02 | 0.01 | 0.00 | -0.02 |
| Balance Sheet | |||||||||||
| Total Assets | 2.80B | 2.70B | 1.46B | 694M | 564M | 632M | 616M | 1.24B | 999M | 984M | 939M |
| Total Liabilities | 1.50B | 1.38B | 1.28B | 522M | 293M | 221M | 201M | 433M | 176M | 165M | 133M |
| Shareholders' Equity | 1.30B | 1.31B | 198M | 50.3M | 150M | 287M | 286M | 678M | 686M | 682M | 666M |
| Cash & Short-term Investments | 218M | 168M | 182M | 147M | 226M | 206M | 233M | 879M | 567M | 505M | 374M |
| Total Debt | 677M | 740M | 518M | 114M | 1.98M | 933K | 33.1M | 46.6M | 4.86M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 365M | 205M | 64.6M | 58.5M | 53.3M | 99.3M | 24.2M | 2.87M | 31.4M | 4.20M | - |
| Capital Expenditure | 44.2M | 39.3M | 5.10M | 20.7M | 22.4M | 16.9M | 42.1M | 10.3M | 12.9M | 9.76M | 6.52M |
| Free Cash Flow | 321M | 166M | 59.5M | 37.8M | 31.0M | 82.4M | -18.0M | -7.43M | 18.5M | -5.56M | -40.1M |
| Ratios | |||||||||||
| ROE | 2.4% | 1.8% | -569.2% | -228.3% | 37.2% | 18.6% | -0.4% | 3.2% | 1.1% | -0.6% | -3.1% |
| ROA | 1.1% | 0.9% | -77.2% | -16.6% | 9.9% | 8.5% | -0.2% | 1.8% | 0.8% | -0.4% | -2.2% |
| Net Profit Margin | 1.9% | 1.5% | -124.9% | -13.7% | 19.5% | 18.0% | -0.3% | 6.4% | 2.4% | -1.6% | -9.1% |
| Debt to Equity | 0.52x | 0.56x | 2.62x | 2.26x | 0.01x | 0.00x | 0.12x | 0.07x | 0.01x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Zhejiang Sunflower Light Energy dividends
- Dividend yield
- 0.00%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 3, 2011
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 8.31K | 0.00 | - |
| 2024 | CNY 1.09M | 0.00 | 13.9% |
| 2023 | CNY 1.66M | 0.00 | 7.6% |
| 2022 | CNY 187K | 0.00 | - |
| 2021 | CNY 60.3K | 0.00 | 0.1% |
| 2020 | CNY 17.6M | 0.02 | 31.4% |
| 2019 | CNY 20.0M | 0.02 | - |
| 2018 | CNY 31.4M | 0.03 | - |
| 2017 | CNY 40.8M | 0.03 | 172.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 22:10 on Sep 4, 2013.
Who owns Zhejiang Sunflower Light Energy
- Insiders 32.19%
- Institutions 0.61%
- Public & others 67.20%
- Shares outstanding 1.29B
- Free float 894M
Zhejiang Sunflower Light Energy company profile
- Company name
- Zhejiang Sunflower Light Energy
- Ticker
- 300111.SHE
- ISIN
- CNE100000SX9
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Aug 27, 2010
- Sector
- Healthcare
- Industry
- Semiconductors & Semiconductor Equipment
- Employees
- 303
- Fiscal year end
- December
- Address
- Sanjiang Road, Shaoxing, China, 312071
- Phone
- 86 575 8891 9159
- Website
- sunowe.com
About Zhejiang Sunflower Light Energy
Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sales of anti-infective, cardiovascular, and digestive system drugs in China and internationally. It offers clarithromycin raw materials, an anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, mycoplasma pneumonia, and urethritis and cervicitis; clarithromycin tablets; azithromycin dispersible tablets and injection for sinusitis, acute otitis media, acute bronchitis, acute exacerbation of chronic bronchitis, streptococcus pneumoniae, pneumonia, haemophilus influenzae, mycoplasma pneumoniae, urethritis, cervicitis, and skin and soft tissue infection. The company also provides roxithromycin capsules to treat pharyngitis and tonsillitis caused by Streptococcus pyogenes, sinusitis, otitis media, acute bronchitis, and acute exacerbation, as well as urethritis, cervicitis, and skin and soft tissue infection. In addition, it offers lacidipine dispersible tablets for the treatment of hypertension; and simvastatin tablets used for hyperlipidemia, coronary heart disease combined with hypercholesterolemia, and children with heterozygous familial hypercholesterolemia. Further, the company provides omeprazole sodium for injection, a digestive system drug, used as an alternative therapy for duodenal and gastric ulcer, reflux esophagitis, and Zollinger-Ellison syndrome. The company was formerly known as Zhejiang Sunflower Great Health Limited Liability Company and changed its name to Zhejiang Sunflower Great Health Co., Ltd. in December 2023. Zhejiang Sunflower Great Health Co., Ltd. was founded in 2005 and is headquartered in Shaoxing, China.
Zhejiang Sunflower Light Energy management
5- Mr. Huaxin ShiGM & Non-Independent Director · born 1968
- Mr. Wei Biao PanCFO, Deputy GM & Director · born 1970
- Ms. Lan LiSecretary of the Board · born 1983
- Danlin WuAccounting Supervisor
- Mr. Jiangang SunDeputy General Manager